Lilly takes patent fight to NAFTA; Claris to sell some infusion business rights;

@FiercePharma: KV says it's set to emerge from bankruptcy. News | Follow @FiercePharma

> Eli Lilly ($LLY) is taking its fight with Canada over the loss of its patent for its ADHD drug Strattera to a NAFTA tribunal. Story

> Fresenius Medical Care says plaintiffs who have sued the company in the U.S. for wrongful death related to its NaturaLyte and GranuFlo products are trying to get them consolidated. Story

> Indian drugmaker Claris has an agreement to sell some of its infusion business in India and emerging markets to two Japanese companies. Story

> The U.K.'s NICE drug cost watchdog has named a new chairman. Story

Medical Device News

 @FierceMedDev: AspenBio Pharma seeks rebirth as Venaxis, with focus on diagnostics. More | Follow @FierceMedDev

@MarkHFierce: A conservative Washington Post blogger calls out medical device tax "hypocrites" who voted for it, and now oppose it. Story | Follow @MarkHFierce

 @DamianFierce: Between FDA earfuls, analyst warnings and, now, a shareholder lawsuit, St. Jude Medical is having a rough winter. Article | Follow @DamianFierce

> Covidien gets Canadian nod for stroke-treating Solitaire. News

> Biocartis bags $44.5M Series D for molecular Dx commercialization. More

> St. Jude faces shareholder suit over Durata claims. Report

Biotech News

 @FierceBiotech: Eli Lilly hits the brakes on PhIII program in arthritis after 'unexpected' results. Story | Follow @FierceBiotech

@JohnCFierce: Who releases PhIII results one endpoint at a time? Stock up, but $ONCY PR is weak, manipulative. Count me skeptical. More | Follow @JohnCFierce

@RyanFierce: AZN missed big in Phase IIb for oral arthritis drug after previous mixed results. Should have killed program earlier? Report | Follow @RyanMFierce

> Ex-Genzyme CEO Termeer returns to his roots at biotech Prosensa. News

> The Medicines Co. bags Bristol, buyout deals for $300M. Article

Vaccine News

> GSK employs mobile phones to up vaccination rates in Africa. Report

> TB vaccine tested in infants of HIV-positive mothers. News

> IDRI fetches $10M from Gates Foundation for adjuvant research. Story

> GAVI Alliance aims to immunize 30 million girls against HPV. Item

> Global pediatric vaccine market to hit $23B by 2015. Article

Pharma Manufacturing News

> Court OKs drug shortage lawsuit against Hospira. News

> Manufacturing at the heart of Teva's $2B cost-cutting drive. Story

> 6 hospitalized as Novartis manufacturing stumbles again. Article

> Manufacturing at the heart of Teva's $2B cost-cutting drive. More

And Finally... Pfizer Consumer Healthcare on Wednesday introduced Robitussin CoughCast, a new interactive tool that allows people to track cough activity in their local area. Item

Suggested Articles

How long can one infusion of CAR-T drug Yescarta continue helping patients with refractory large B-cell lymphoma? Pretty long, Gilead showed Saturday.

AbbVie and Roche have been fielding their fair share of questions about how well their fixed-duration regimen of Venclexta and Rituxan could keep chro

Saturday, AstraZeneca revealed more of the data that convinced the FDA to green-light Calquence in previously untreated chronic lymphocytic leukemia.